Bharat Biotech Gets SEC Nod to Begin Phase III Trial of Inactivated Chikungunya Vaccine We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Tightens RTI Appeal Timelines, Division Heads to Face Penalties for Lapses We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Syneos Health Asked to Clarify Phase II Tacrolimus Trial Protocol by CDSCO Panel We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Panel Asks Astellas Pharma to Update Enzalutamide Label After Phase IV Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Panel Flags Trial Death, Seeks Causality Report from Reliance Life Sciences on EtanerRel We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Spurious Drugs Alert: Diazepam, PAN 40, and PAN-D Capsules Under Investigation We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Panel Approves Cipla’s Levormeloxifene Study Amendment, Mandates Transvaginal Sonography We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
More than 20 associations representing medium, small and micro pharmaceutical companies have appealed to the union health minister JP Nadda flagging their concerns over the central drug regulatory body’s decision to implement higher manufacturing standards or face closure. According to the associations the “abrupt” implementation timelines leave little scope for the companies to prepare and…
Biocon Gets CDSCO Panel Nod to Import Aflibercept Injection for Eye Disorders, Phase IV Trial Mandated We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
94 Drug, Medical Product Batches Fail CDSCO Quality Tests in August We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link